FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4256322572> ?p ?o ?g. }

• W4256322572 endingPage "2052" @default.
• W4256322572 startingPage "2041" @default.
• W4256322572 abstract "Bcl-2 and bcl-xL function as suppressors of programmed cell death. The expression of bcl-2 protein in vivo is associated with long-lived hematopoietic cells such as mature lymphocytes and early myeloid progenitors. Bcl-xL, a homologue of bcl-2, is also expressed in lymphocytes and thymocytes. In contrast, the bcl-2-related proteins (bax, bad, and bak) act by promoting apoptotic cell death as shown from their expression in hematopoietic cell lines. We analyzed the expression of bcl-2 and bcl-x proteins in hematopoietic precursors obtained from various cell sources in adult mobilized peripheral blood collected from 13 patients with solid tumors, 8 adult bone marrow, and 12 umbilical cord blood. The analysis was based on the expression of the proliferation and activation specific antigens, CD38 and class II (HLA-DR). Similarly, we analyzed the expression of bcl-2-related proteins bcl-xL, bax, bad, and bak before and during ex-vivo expansion. Hematopoietic precursors expressing strongly the CD34 antigen (CD34s+) and lacking CD38 or HLA-DR expression were analyzed by using three-color immunofluorescence staining. The majority of CD34+ cells expressed bcl-2 and unexpectedly showed a bimodal distribution of low and high expression. More cells that lacked or expressed low density CD38 expressed low bcl-2 than the more differentiated counterparts (those with high density CD38). Immaturity (ie, little or no HLA-DR) is associated with the expression of low bcl-2 compared with HLA-DR+. However, HLA-DR−/low population contained a lower number of cells expressing low bcl-2 (30% to 40%) than CD38−/low in comparable samples. The hematopoietic precursors with bcl-2low and bcl-2high formed a homogeneous population of undifferentiated lymphoid-like cells having a similar forward scatter. These cells expressed strongly the bcl-xL protein (>95%) but were bax low (4% to 12%), bad low (0% to 0.8%), and bak low (0% to 3%). The expression of apoptosis specific protein (ASP) was also low (3.4% ± 3.1%) as was Annexin V. In addition, the CD34+/CD38−showed low cell cycle activity (<2.2%). Induction of apoptosis by overnight incubation of CD34 cells in serum-deprived medium resulted in the upregulation of bcl-2 as a single population histogram. Thus, these results suggest that in quiescent hematopoietic precursors, the bcl-2 protein plays a less prominent role as a survival promoter than bcl-xL and that the low bcl-2 expression did not promote apoptosis. During day 10 of ex vivo expansion of CD34+cells in liquid culture containing stem cell factor, interleukin-3 (IL-3), IL-6, IL-1β, and erythropoietin, the CD34+/CD38− cells expressed high bcl-2 as a single population histogram, and greater than 90% were bcl-xL high. However, the expression of pro- and apoptotic antigens increased: bax (10% to 15%), bad (5% to 8%), bak (6% to 14%), and ASP (6% to 10%). These results show the importance of monitoring the expression of these proteins when defining the culture conditions for ex vivo expansion. © 1998 by The American Society of Hematology." @default.
• W4256322572 created "2022-05-12" @default.
• W4256322572 creator A5031165822 @default.
• W4256322572 creator A5062973691 @default.
• W4256322572 creator A5081835456 @default.
• W4256322572 date "1998-09-15" @default.
• W4256322572 modified "2023-09-28" @default.
• W4256322572 title "Apoptotic Regulation in Primitive Hematopoietic Precursors" @default.
• W4256322572 cites W1481112340 @default.
• W4256322572 cites W1511084133 @default.
• W4256322572 cites W1554380543 @default.
• W4256322572 cites W1584160754 @default.
• W4256322572 cites W1584828020 @default.
• W4256322572 cites W1598719623 @default.
• W4256322572 cites W1913179054 @default.
• W4256322572 cites W1966144382 @default.
• W4256322572 cites W1974234931 @default.
• W4256322572 cites W1977404622 @default.
• W4256322572 cites W1991865867 @default.
• W4256322572 cites W2000894919 @default.
• W4256322572 cites W2001917467 @default.
• W4256322572 cites W2002201946 @default.
• W4256322572 cites W2004072663 @default.
• W4256322572 cites W2009183764 @default.
• W4256322572 cites W2028625808 @default.
• W4256322572 cites W2033847504 @default.
• W4256322572 cites W2036274324 @default.
• W4256322572 cites W2040112003 @default.
• W4256322572 cites W2043066069 @default.
• W4256322572 cites W2048428832 @default.
• W4256322572 cites W2051219590 @default.
• W4256322572 cites W2057289234 @default.
• W4256322572 cites W2057713336 @default.
• W4256322572 cites W2063176993 @default.
• W4256322572 cites W2070862399 @default.
• W4256322572 cites W2078532650 @default.
• W4256322572 cites W2092691564 @default.
• W4256322572 cites W2102671287 @default.
• W4256322572 cites W2105695958 @default.
• W4256322572 cites W2131069827 @default.
• W4256322572 cites W2134979684 @default.
• W4256322572 cites W2166291746 @default.
• W4256322572 cites W2209146078 @default.
• W4256322572 cites W2232251649 @default.
• W4256322572 cites W2257934670 @default.
• W4256322572 cites W2339456987 @default.
• W4256322572 cites W2409830639 @default.
• W4256322572 cites W2413138514 @default.
• W4256322572 cites W2415581815 @default.
• W4256322572 cites W4229662680 @default.
• W4256322572 cites W4236339283 @default.
• W4256322572 cites W4238246846 @default.
• W4256322572 cites W43460215 @default.
• W4256322572 cites W74017565 @default.
• W4256322572 doi "https://doi.org/10.1182/blood.v92.6.2041.418k34_2041_2052" @default.
• W4256322572 hasPublicationYear "1998" @default.
• W4256322572 type Work @default.
• W4256322572 citedByCount "2" @default.
• W4256322572 crossrefType "journal-article" @default.
• W4256322572 hasAuthorship W4256322572A5031165822 @default.
• W4256322572 hasAuthorship W4256322572A5062973691 @default.
• W4256322572 hasAuthorship W4256322572A5081835456 @default.
• W4256322572 hasConcept C10205521 @default.
• W4256322572 hasConcept C109159458 @default.
• W4256322572 hasConcept C147483822 @default.
• W4256322572 hasConcept C153911025 @default.
• W4256322572 hasConcept C159912055 @default.
• W4256322572 hasConcept C188280979 @default.
• W4256322572 hasConcept C190283241 @default.
• W4256322572 hasConcept C201750760 @default.
• W4256322572 hasConcept C203014093 @default.
• W4256322572 hasConcept C2779067128 @default.
• W4256322572 hasConcept C2779282312 @default.
• W4256322572 hasConcept C2780007613 @default.
• W4256322572 hasConcept C28328180 @default.
• W4256322572 hasConcept C2908647359 @default.
• W4256322572 hasConcept C31573885 @default.
• W4256322572 hasConcept C54355233 @default.
• W4256322572 hasConcept C71924100 @default.
• W4256322572 hasConcept C86803240 @default.
• W4256322572 hasConcept C95444343 @default.
• W4256322572 hasConcept C99454951 @default.
• W4256322572 hasConceptScore W4256322572C10205521 @default.
• W4256322572 hasConceptScore W4256322572C109159458 @default.
• W4256322572 hasConceptScore W4256322572C147483822 @default.
• W4256322572 hasConceptScore W4256322572C153911025 @default.
• W4256322572 hasConceptScore W4256322572C159912055 @default.
• W4256322572 hasConceptScore W4256322572C188280979 @default.
• W4256322572 hasConceptScore W4256322572C190283241 @default.
• W4256322572 hasConceptScore W4256322572C201750760 @default.
• W4256322572 hasConceptScore W4256322572C203014093 @default.
• W4256322572 hasConceptScore W4256322572C2779067128 @default.
• W4256322572 hasConceptScore W4256322572C2779282312 @default.
• W4256322572 hasConceptScore W4256322572C2780007613 @default.
• W4256322572 hasConceptScore W4256322572C28328180 @default.
• W4256322572 hasConceptScore W4256322572C2908647359 @default.
• W4256322572 hasConceptScore W4256322572C31573885 @default.
• W4256322572 hasConceptScore W4256322572C54355233 @default.

• next